Cardiol Therapeutics Inc. (CRDL)
NASDAQ: CRDL
· Real-Time Price · USD
1.31
-0.03 (-2.24%)
At close: Aug 15, 2025, 12:14 PM
Cardiol Therapeutics Income Statement
Financials in CAD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 78.76K | 78.76K | 78.76K | 78.76K | n/a |
Cost of Revenue | 61.91K | 123.53K | 190.29K | 255.19K | 251.77K | 248.35K | 239.63K | 229.21K | 224.49K | 219.91K | 217.46K | 218.58K | 164.8K | 165.8K | 110.21K | 54.62K | 54.62K |
Gross Profit | -61.91K | -123.53K | -190.29K | -255.19K | -251.77K | -248.35K | -239.63K | -229.21K | -224.49K | -219.91K | -217.46K | -218.58K | -86.04K | -87.04K | -31.45K | 24.14K | -54.62K |
Operating Income | -30.31M | -30.29M | -38.32M | -31.83M | -28.72M | -28.25M | -30.31M | -40.57M | -47.73M | -50.34M | -60.14M | -52.51M | -46.99M | -45.47M | -35.18M | -29.28M | -26.59M |
Interest Income | 1.06M | 1.19M | 887.02K | 1.2M | 1.42M | 1.59M | 2.17M | 2.05M | 1.71M | 1.24M | 680.75K | 327.34K | 161.49K | 106K | 97.77K | 85.19K | 73.62K |
Pretax Income | -35.79M | -36.68M | -36.14M | -29.34M | -30.22M | -28.13M | -28.01M | -30.05M | -29.07M | -30.93M | -29.67M | -31.61M | -31.68M | -31.64M | -35.05M | -29.54M | -26.6M |
Net Income | -35.79M | -36.68M | -36.14M | -29.34M | -30.22M | -28.13M | -28.01M | -30.05M | -29.07M | -30.93M | -29.67M | -31.61M | -31.68M | -31.64M | -35.05M | -29.54M | -26.6M |
Selling & General & Admin | 25.83M | 26.2M | 24.36M | 19.05M | 16.86M | 15.49M | 15.05M | 18.1M | 20.09M | 22.37M | 28.47M | 27.91M | 27.63M | 28.01M | 20.78M | 15.66M | 13.83M |
Research & Development | 14.45M | 14.01M | 13.82M | 12.65M | 13.42M | 14.22M | 15.8M | 18.31M | 19.24M | 18.96M | 16.87M | 14.37M | 11.87M | 10.63M | 14.31M | 13.62M | 12.54M |
Other Expenses | 24.99K | 28.22K | 28.22K | 28.22K | 28.22K | n/a | n/a | n/a | n/a | n/a | 19.15K | 112.23K | 112.23K | 112.23K | 93.08K | n/a | n/a |
Operating Expenses | 40.3M | 40.22M | 38.19M | 31.7M | 30.28M | 29.72M | 30.85M | 36.42M | 39.33M | 41.34M | 45.34M | 42.28M | 39.55M | 38.74M | 35.26M | 29.51M | 26.59M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | -61.62K | 3.86M | 3.86M | 3.86M | 3.92M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 40.3M | 40.28M | 38.32M | 31.83M | 30.4M | 29.79M | 30.85M | 36.42M | 39.33M | 41.34M | 45.34M | 42.28M | 39.55M | 38.74M | 35.26M | 29.51M | 26.59M |
Income Tax Expense | n/a | -2 | -4 | -4 | 1.16M | 460.3K | -1.12M | -6.2M | -10.1M | -10.24M | -15.48M | -10.56M | -7.68M | -6.91M | -93.27K | 67.27K | -70.36K |
Shares Outstanding (Basic) | 82.61M | 69.84M | 69.84M | 68.75M | 67.26M | 65.35M | 64.49M | 64.11M | 64.09M | 63.83M | 62.34M | 61.93M | 61.92M | 56.89M | 43.17M | 40.06M | 34.6M |
Shares Outstanding (Diluted) | 82.61M | 69.84M | 69.84M | 68.75M | 67.26M | 65.35M | 64.49M | 64.11M | 64.09M | 64.04M | 62.34M | 61.93M | 61.93M | 56.89M | 43.17M | 40.06M | 34.61M |
EPS (Basic) | -0.5 | -0.54 | -0.54 | -0.45 | -0.47 | -0.44 | -0.44 | -0.48 | -0.46 | -0.49 | -0.48 | -0.58 | -0.64 | -0.76 | -0.94 | -0.84 | -0.81 |
EPS (Diluted) | -0.5 | -0.54 | -0.54 | -0.45 | -0.47 | -0.44 | -0.44 | -0.48 | -0.46 | -0.49 | -0.48 | -0.58 | -0.64 | -0.76 | -0.94 | -0.84 | -0.81 |
EBITDA | -39.96M | -39.9M | -37.92M | -31.59M | -30.17M | -29.56M | -30.67M | -36.23M | -39.15M | -41.16M | -45.16M | -42.1M | -39.29M | -38.48M | -35M | -29.25M | -26.39M |
EBIT | -40.3M | -40.28M | -38.32M | -31.83M | -30.4M | -29.79M | -30.85M | -36.42M | -39.33M | -41.34M | -45.34M | -42.28M | -39.47M | -38.66M | -35.23M | -29.48M | -26.64M |
Depreciation & Amortization | 336.48K | 373.11K | 391.38K | 255.19K | 251.77K | 248.35K | 239.63K | 229.21K | 224.49K | 219.91K | 217.46K | 218.58K | 219.42K | 220.42K | 223.22K | 224.98K | 227.81K |